カテゴリー： 世界, 医療/バイオ, LP Information

世界のメチルプレドニゾロン製剤市場予測 2023年-2029年

【英語タイトル】Global Methylprednisolone Preparations Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11210）・商品コード：LP23DC11210
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：104
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のメチルプレドニゾロン製剤市場」は、過去の販売実績から2022年の世界のメチルプレドニゾロン製剤の総販売量を検討し、2023年から2029年の予測されるメチルプレドニゾロン製剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のメチルプレドニゾロン製剤の市場規模を掲載し、XXX百万米ドル規模の世界のメチルプレドニゾロン製剤市場の詳細な分析を提供します。本インサイトレポートは、世界のメチルプレドニゾロン製剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のメチルプレドニゾロン製剤市場における各社の独自のポジションをより深く理解するために、メチルプレドニゾロン製剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のメチルプレドニゾロン製剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。メチルプレドニゾロン製剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。メチルプレドニゾロン製剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。メチルプレドニゾロン製剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

メチルプレドニゾロン製剤の世界主要メーカーとしては、Pfizer、 Sandoz、 Hikma Pharmaceuticals、 Teva Pharmaceutical、 Lupin、 Zydus Pharmaceuticals、 Sinopharm Group Rongsheng Pharmaceutical、 Tianjin Tianyao Pharmaceuticals、 Liaoning Haisco Pharmaceutical、 Nang Kuang Pharmaceutical、 Chongqing Huapont Pharmaceutical、 Zhejiang Xianju Pharmaceutical、 Fuan Pharmaceuticalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のメチルプレドニゾロン製剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではメチルプレドニゾロン製剤市場をセグメンテーションし、種類別 (錠剤、注射剤)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：錠剤、注射剤

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のメチルプレドニゾロン製剤市場の10年間の市場状況・展望は？
・世界および地域別に見たメチルプレドニゾロン製剤市場成長の要因は何か？
・メチルプレドニゾロン製剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・メチルプレドニゾロン製剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：メチルプレドニゾロン製剤の年間販売量2018-2029、地域別現状・将来分析
・メチルプレドニゾロン製剤の種類別セグメント：錠剤、注射剤
・メチルプレドニゾロン製剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・メチルプレドニゾロン製剤の用途別セグメント：病院、診療所、その他
・メチルプレドニゾロン製剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のメチルプレドニゾロン製剤市場
・企業別のグローバルメチルプレドニゾロン製剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のメチルプレドニゾロン製剤の年間売上：2018-2023年の売上、市場シェア
・企業別のメチルプレドニゾロン製剤販売価格
・主要企業のメチルプレドニゾロン製剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

メチルプレドニゾロン製剤の地域別レビュー
・地域別のメチルプレドニゾロン製剤市場規模2018-2023：年間販売量、売上
・主要国別のメチルプレドニゾロン製剤市場規模2018-2023：年間販売量、売上
・南北アメリカのメチルプレドニゾロン製剤販売の成長
・アジア太平洋のメチルプレドニゾロン製剤販売の成長
・ヨーロッパのメチルプレドニゾロン製剤販売の成長
・中東・アフリカのメチルプレドニゾロン製剤販売の成長

南北アメリカ市場
・南北アメリカの国別のメチルプレドニゾロン製剤販売量、売上（2018-2023）
・南北アメリカのメチルプレドニゾロン製剤の種類別販売量
・南北アメリカのメチルプレドニゾロン製剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のメチルプレドニゾロン製剤販売量、売上（2018-2023）
・アジア太平洋のメチルプレドニゾロン製剤の種類別販売量
・アジア太平洋のメチルプレドニゾロン製剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のメチルプレドニゾロン製剤販売量、売上（2018-2023）
・ヨーロッパのメチルプレドニゾロン製剤の種類別販売量
・ヨーロッパのメチルプレドニゾロン製剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のメチルプレドニゾロン製剤販売量、売上（2018-2023）
・中東・アフリカのメチルプレドニゾロン製剤の種類別販売量
・中東・アフリカのメチルプレドニゾロン製剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・メチルプレドニゾロン製剤の製造コスト構造分析
・メチルプレドニゾロン製剤の製造プロセス分析
・メチルプレドニゾロン製剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・メチルプレドニゾロン製剤の主要なグローバル販売業者
・メチルプレドニゾロン製剤の主要なグローバル顧客

地域別のメチルプレドニゾロン製剤市場予測レビュー
・地域別のメチルプレドニゾロン製剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・メチルプレドニゾロン製剤の種類別市場規模予測
・メチルプレドニゾロン製剤の用途別市場規模予測

主要企業分析
Pfizer、 Sandoz、 Hikma Pharmaceuticals、 Teva Pharmaceutical、 Lupin、 Zydus Pharmaceuticals、 Sinopharm Group Rongsheng Pharmaceutical、 Tianjin Tianyao Pharmaceuticals、 Liaoning Haisco Pharmaceutical、 Nang Kuang Pharmaceutical、 Chongqing Huapont Pharmaceutical、 Zhejiang Xianju Pharmaceutical、 Fuan Pharmaceutical
・企業情報
・メチルプレドニゾロン製剤製品
・メチルプレドニゾロン製剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Methylprednisolone Preparations market size is projected to grow from US$ 47 million in 2022 to US$ 66 million in 2029; it is expected to grow at a CAGR of 5.0% from 2023 to 2029.
United States market for Methylprednisolone Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Methylprednisolone Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Methylprednisolone Preparations is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Methylprednisolone Preparations players cover Pfizer, Sandoz, Hikma Pharmaceuticals, Teva Pharmaceutical, Lupin, Zydus Pharmaceuticals, Sinopharm Group Rongsheng Pharmaceutical, Tianjin Tianyao Pharmaceuticals and Liaoning Haisco Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Methylprednisolone is a corticosteroid medication that is used to treat a wide range of inflammatory and autoimmune conditions, such as asthma, arthritis, allergies, and certain types of cancer.
LPI (LP Information)’ newest research report, the “Methylprednisolone Preparations Industry Forecast” looks at past sales and reviews total world Methylprednisolone Preparations sales in 2022, providing a comprehensive analysis by region and market sector of projected Methylprednisolone Preparations sales for 2023 through 2029. With Methylprednisolone Preparations sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Methylprednisolone Preparations industry.
This Insight Report provides a comprehensive analysis of the global Methylprednisolone Preparations landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Methylprednisolone Preparations portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Methylprednisolone Preparations market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Methylprednisolone Preparations and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Methylprednisolone Preparations.
This report presents a comprehensive overview, market shares, and growth opportunities of Methylprednisolone Preparations market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tablets
Injection
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Pfizer
Sandoz
Hikma Pharmaceuticals
Teva Pharmaceutical
Lupin
Zydus Pharmaceuticals
Sinopharm Group Rongsheng Pharmaceutical
Tianjin Tianyao Pharmaceuticals
Liaoning Haisco Pharmaceutical
Nang Kuang Pharmaceutical
Chongqing Huapont Pharmaceutical
Zhejiang Xianju Pharmaceutical
Fuan Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Methylprednisolone Preparations market?
What factors are driving Methylprednisolone Preparations market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Methylprednisolone Preparations market opportunities vary by end market size?
How does Methylprednisolone Preparations break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Methylprednisolone Preparations Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Methylprednisolone Preparations by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Methylprednisolone Preparations by Country/Region, 2018, 2022 & 2029
2.2 Methylprednisolone Preparations Segment by Type
2.2.1 Tablets
2.2.2 Injection
2.3 Methylprednisolone Preparations Sales by Type
2.3.1 Global Methylprednisolone Preparations Sales Market Share by Type (2018-2023)
2.3.2 Global Methylprednisolone Preparations Revenue and Market Share by Type (2018-2023)
2.3.3 Global Methylprednisolone Preparations Sale Price by Type (2018-2023)
2.4 Methylprednisolone Preparations Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Methylprednisolone Preparations Sales by Application
2.5.1 Global Methylprednisolone Preparations Sale Market Share by Application (2018-2023)
2.5.2 Global Methylprednisolone Preparations Revenue and Market Share by Application (2018-2023)
2.5.3 Global Methylprednisolone Preparations Sale Price by Application (2018-2023)
3 Global Methylprednisolone Preparations by Company
3.1 Global Methylprednisolone Preparations Breakdown Data by Company
3.1.1 Global Methylprednisolone Preparations Annual Sales by Company (2018-2023)
3.1.2 Global Methylprednisolone Preparations Sales Market Share by Company (2018-2023)
3.2 Global Methylprednisolone Preparations Annual Revenue by Company (2018-2023)
3.2.1 Global Methylprednisolone Preparations Revenue by Company (2018-2023)
3.2.2 Global Methylprednisolone Preparations Revenue Market Share by Company (2018-2023)
3.3 Global Methylprednisolone Preparations Sale Price by Company
3.4 Key Manufacturers Methylprednisolone Preparations Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Methylprednisolone Preparations Product Location Distribution
3.4.2 Players Methylprednisolone Preparations Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Methylprednisolone Preparations by Geographic Region
4.1 World Historic Methylprednisolone Preparations Market Size by Geographic Region (2018-2023)
4.1.1 Global Methylprednisolone Preparations Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Methylprednisolone Preparations Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Methylprednisolone Preparations Market Size by Country/Region (2018-2023)
4.2.1 Global Methylprednisolone Preparations Annual Sales by Country/Region (2018-2023)
4.2.2 Global Methylprednisolone Preparations Annual Revenue by Country/Region (2018-2023)
4.3 Americas Methylprednisolone Preparations Sales Growth
4.4 APAC Methylprednisolone Preparations Sales Growth
4.5 Europe Methylprednisolone Preparations Sales Growth
4.6 Middle East & Africa Methylprednisolone Preparations Sales Growth
5 Americas
5.1 Americas Methylprednisolone Preparations Sales by Country
5.1.1 Americas Methylprednisolone Preparations Sales by Country (2018-2023)
5.1.2 Americas Methylprednisolone Preparations Revenue by Country (2018-2023)
5.2 Americas Methylprednisolone Preparations Sales by Type
5.3 Americas Methylprednisolone Preparations Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Methylprednisolone Preparations Sales by Region
6.1.1 APAC Methylprednisolone Preparations Sales by Region (2018-2023)
6.1.2 APAC Methylprednisolone Preparations Revenue by Region (2018-2023)
6.2 APAC Methylprednisolone Preparations Sales by Type
6.3 APAC Methylprednisolone Preparations Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Methylprednisolone Preparations by Country
7.1.1 Europe Methylprednisolone Preparations Sales by Country (2018-2023)
7.1.2 Europe Methylprednisolone Preparations Revenue by Country (2018-2023)
7.2 Europe Methylprednisolone Preparations Sales by Type
7.3 Europe Methylprednisolone Preparations Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Methylprednisolone Preparations by Country
8.1.1 Middle East & Africa Methylprednisolone Preparations Sales by Country (2018-2023)
8.1.2 Middle East & Africa Methylprednisolone Preparations Revenue by Country (2018-2023)
8.2 Middle East & Africa Methylprednisolone Preparations Sales by Type
8.3 Middle East & Africa Methylprednisolone Preparations Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Methylprednisolone Preparations
10.3 Manufacturing Process Analysis of Methylprednisolone Preparations
10.4 Industry Chain Structure of Methylprednisolone Preparations
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Methylprednisolone Preparations Distributors
11.3 Methylprednisolone Preparations Customer
12 World Forecast Review for Methylprednisolone Preparations by Geographic Region
12.1 Global Methylprednisolone Preparations Market Size Forecast by Region
12.1.1 Global Methylprednisolone Preparations Forecast by Region (2024-2029)
12.1.2 Global Methylprednisolone Preparations Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Methylprednisolone Preparations Forecast by Type
12.7 Global Methylprednisolone Preparations Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Methylprednisolone Preparations Product Portfolios and Specifications
13.1.3 Pfizer Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Sandoz
13.2.1 Sandoz Company Information
13.2.2 Sandoz Methylprednisolone Preparations Product Portfolios and Specifications
13.2.3 Sandoz Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sandoz Main Business Overview
13.2.5 Sandoz Latest Developments
13.3 Hikma Pharmaceuticals
13.3.1 Hikma Pharmaceuticals Company Information
13.3.2 Hikma Pharmaceuticals Methylprednisolone Preparations Product Portfolios and Specifications
13.3.3 Hikma Pharmaceuticals Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Hikma Pharmaceuticals Main Business Overview
13.3.5 Hikma Pharmaceuticals Latest Developments
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Information
13.4.2 Teva Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
13.4.3 Teva Pharmaceutical Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Pharmaceutical Main Business Overview
13.4.5 Teva Pharmaceutical Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin Methylprednisolone Preparations Product Portfolios and Specifications
13.5.3 Lupin Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Zydus Pharmaceuticals
13.6.1 Zydus Pharmaceuticals Company Information
13.6.2 Zydus Pharmaceuticals Methylprednisolone Preparations Product Portfolios and Specifications
13.6.3 Zydus Pharmaceuticals Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Zydus Pharmaceuticals Main Business Overview
13.6.5 Zydus Pharmaceuticals Latest Developments
13.7 Sinopharm Group Rongsheng Pharmaceutical
13.7.1 Sinopharm Group Rongsheng Pharmaceutical Company Information
13.7.2 Sinopharm Group Rongsheng Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
13.7.3 Sinopharm Group Rongsheng Pharmaceutical Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sinopharm Group Rongsheng Pharmaceutical Main Business Overview
13.7.5 Sinopharm Group Rongsheng Pharmaceutical Latest Developments
13.8 Tianjin Tianyao Pharmaceuticals
13.8.1 Tianjin Tianyao Pharmaceuticals Company Information
13.8.2 Tianjin Tianyao Pharmaceuticals Methylprednisolone Preparations Product Portfolios and Specifications
13.8.3 Tianjin Tianyao Pharmaceuticals Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Tianjin Tianyao Pharmaceuticals Main Business Overview
13.8.5 Tianjin Tianyao Pharmaceuticals Latest Developments
13.9 Liaoning Haisco Pharmaceutical
13.9.1 Liaoning Haisco Pharmaceutical Company Information
13.9.2 Liaoning Haisco Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
13.9.3 Liaoning Haisco Pharmaceutical Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Liaoning Haisco Pharmaceutical Main Business Overview
13.9.5 Liaoning Haisco Pharmaceutical Latest Developments
13.10 Nang Kuang Pharmaceutical
13.10.1 Nang Kuang Pharmaceutical Company Information
13.10.2 Nang Kuang Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
13.10.3 Nang Kuang Pharmaceutical Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nang Kuang Pharmaceutical Main Business Overview
13.10.5 Nang Kuang Pharmaceutical Latest Developments
13.11 Chongqing Huapont Pharmaceutical
13.11.1 Chongqing Huapont Pharmaceutical Company Information
13.11.2 Chongqing Huapont Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
13.11.3 Chongqing Huapont Pharmaceutical Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Chongqing Huapont Pharmaceutical Main Business Overview
13.11.5 Chongqing Huapont Pharmaceutical Latest Developments
13.12 Zhejiang Xianju Pharmaceutical
13.12.1 Zhejiang Xianju Pharmaceutical Company Information
13.12.2 Zhejiang Xianju Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
13.12.3 Zhejiang Xianju Pharmaceutical Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Zhejiang Xianju Pharmaceutical Main Business Overview
13.12.5 Zhejiang Xianju Pharmaceutical Latest Developments
13.13 Fuan Pharmaceutical
13.13.1 Fuan Pharmaceutical Company Information
13.13.2 Fuan Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
13.13.3 Fuan Pharmaceutical Methylprednisolone Preparations Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Fuan Pharmaceutical Main Business Overview
13.13.5 Fuan Pharmaceutical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Methylprednisolone Preparations Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Methylprednisolone Preparations Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Injection
Table 5. Global Methylprednisolone Preparations Sales by Type (2018-2023) & (K Units)
Table 6. Global Methylprednisolone Preparations Sales Market Share by Type (2018-2023)
Table 7. Global Methylprednisolone Preparations Revenue by Type (2018-2023) & ($ million)
Table 8. Global Methylprednisolone Preparations Revenue Market Share by Type (2018-2023)
Table 9. Global Methylprednisolone Preparations Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Methylprednisolone Preparations Sales by Application (2018-2023) & (K Units)
Table 11. Global Methylprednisolone Preparations Sales Market Share by Application (2018-2023)
Table 12. Global Methylprednisolone Preparations Revenue by Application (2018-2023)
Table 13. Global Methylprednisolone Preparations Revenue Market Share by Application (2018-2023)
Table 14. Global Methylprednisolone Preparations Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Methylprednisolone Preparations Sales by Company (2018-2023) & (K Units)
Table 16. Global Methylprednisolone Preparations Sales Market Share by Company (2018-2023)
Table 17. Global Methylprednisolone Preparations Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Methylprednisolone Preparations Revenue Market Share by Company (2018-2023)
Table 19. Global Methylprednisolone Preparations Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Methylprednisolone Preparations Producing Area Distribution and Sales Area
Table 21. Players Methylprednisolone Preparations Products Offered
Table 22. Methylprednisolone Preparations Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Methylprednisolone Preparations Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Methylprednisolone Preparations Sales Market Share Geographic Region (2018-2023)
Table 27. Global Methylprednisolone Preparations Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Methylprednisolone Preparations Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Methylprednisolone Preparations Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Methylprednisolone Preparations Sales Market Share by Country/Region (2018-2023)
Table 31. Global Methylprednisolone Preparations Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Methylprednisolone Preparations Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Methylprednisolone Preparations Sales by Country (2018-2023) & (K Units)
Table 34. Americas Methylprednisolone Preparations Sales Market Share by Country (2018-2023)
Table 35. Americas Methylprednisolone Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Methylprednisolone Preparations Revenue Market Share by Country (2018-2023)
Table 37. Americas Methylprednisolone Preparations Sales by Type (2018-2023) & (K Units)
Table 38. Americas Methylprednisolone Preparations Sales by Application (2018-2023) & (K Units)
Table 39. APAC Methylprednisolone Preparations Sales by Region (2018-2023) & (K Units)
Table 40. APAC Methylprednisolone Preparations Sales Market Share by Region (2018-2023)
Table 41. APAC Methylprednisolone Preparations Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Methylprednisolone Preparations Revenue Market Share by Region (2018-2023)
Table 43. APAC Methylprednisolone Preparations Sales by Type (2018-2023) & (K Units)
Table 44. APAC Methylprednisolone Preparations Sales by Application (2018-2023) & (K Units)
Table 45. Europe Methylprednisolone Preparations Sales by Country (2018-2023) & (K Units)
Table 46. Europe Methylprednisolone Preparations Sales Market Share by Country (2018-2023)
Table 47. Europe Methylprednisolone Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Methylprednisolone Preparations Revenue Market Share by Country (2018-2023)
Table 49. Europe Methylprednisolone Preparations Sales by Type (2018-2023) & (K Units)
Table 50. Europe Methylprednisolone Preparations Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Methylprednisolone Preparations Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Methylprednisolone Preparations Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Methylprednisolone Preparations Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Methylprednisolone Preparations Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Methylprednisolone Preparations Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Methylprednisolone Preparations Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Methylprednisolone Preparations
Table 58. Key Market Challenges & Risks of Methylprednisolone Preparations
Table 59. Key Industry Trends of Methylprednisolone Preparations
Table 60. Methylprednisolone Preparations Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Methylprednisolone Preparations Distributors List
Table 63. Methylprednisolone Preparations Customer List
Table 64. Global Methylprednisolone Preparations Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Methylprednisolone Preparations Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Methylprednisolone Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Methylprednisolone Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Methylprednisolone Preparations Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Methylprednisolone Preparations Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Methylprednisolone Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Methylprednisolone Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Methylprednisolone Preparations Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Methylprednisolone Preparations Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Methylprednisolone Preparations Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Methylprednisolone Preparations Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Methylprednisolone Preparations Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Methylprednisolone Preparations Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Pfizer Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Methylprednisolone Preparations Product Portfolios and Specifications
Table 80. Pfizer Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Pfizer Main Business
Table 82. Pfizer Latest Developments
Table 83. Sandoz Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 84. Sandoz Methylprednisolone Preparations Product Portfolios and Specifications
Table 85. Sandoz Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Sandoz Main Business
Table 87. Sandoz Latest Developments
Table 88. Hikma Pharmaceuticals Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 89. Hikma Pharmaceuticals Methylprednisolone Preparations Product Portfolios and Specifications
Table 90. Hikma Pharmaceuticals Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Hikma Pharmaceuticals Main Business
Table 92. Hikma Pharmaceuticals Latest Developments
Table 93. Teva Pharmaceutical Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
Table 95. Teva Pharmaceutical Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Teva Pharmaceutical Main Business
Table 97. Teva Pharmaceutical Latest Developments
Table 98. Lupin Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 99. Lupin Methylprednisolone Preparations Product Portfolios and Specifications
Table 100. Lupin Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Lupin Main Business
Table 102. Lupin Latest Developments
Table 103. Zydus Pharmaceuticals Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 104. Zydus Pharmaceuticals Methylprednisolone Preparations Product Portfolios and Specifications
Table 105. Zydus Pharmaceuticals Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Zydus Pharmaceuticals Main Business
Table 107. Zydus Pharmaceuticals Latest Developments
Table 108. Sinopharm Group Rongsheng Pharmaceutical Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 109. Sinopharm Group Rongsheng Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
Table 110. Sinopharm Group Rongsheng Pharmaceutical Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Sinopharm Group Rongsheng Pharmaceutical Main Business
Table 112. Sinopharm Group Rongsheng Pharmaceutical Latest Developments
Table 113. Tianjin Tianyao Pharmaceuticals Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 114. Tianjin Tianyao Pharmaceuticals Methylprednisolone Preparations Product Portfolios and Specifications
Table 115. Tianjin Tianyao Pharmaceuticals Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Tianjin Tianyao Pharmaceuticals Main Business
Table 117. Tianjin Tianyao Pharmaceuticals Latest Developments
Table 118. Liaoning Haisco Pharmaceutical Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 119. Liaoning Haisco Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
Table 120. Liaoning Haisco Pharmaceutical Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Liaoning Haisco Pharmaceutical Main Business
Table 122. Liaoning Haisco Pharmaceutical Latest Developments
Table 123. Nang Kuang Pharmaceutical Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 124. Nang Kuang Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
Table 125. Nang Kuang Pharmaceutical Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Nang Kuang Pharmaceutical Main Business
Table 127. Nang Kuang Pharmaceutical Latest Developments
Table 128. Chongqing Huapont Pharmaceutical Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 129. Chongqing Huapont Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
Table 130. Chongqing Huapont Pharmaceutical Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Chongqing Huapont Pharmaceutical Main Business
Table 132. Chongqing Huapont Pharmaceutical Latest Developments
Table 133. Zhejiang Xianju Pharmaceutical Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 134. Zhejiang Xianju Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
Table 135. Zhejiang Xianju Pharmaceutical Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Zhejiang Xianju Pharmaceutical Main Business
Table 137. Zhejiang Xianju Pharmaceutical Latest Developments
Table 138. Fuan Pharmaceutical Basic Information, Methylprednisolone Preparations Manufacturing Base, Sales Area and Its Competitors
Table 139. Fuan Pharmaceutical Methylprednisolone Preparations Product Portfolios and Specifications
Table 140. Fuan Pharmaceutical Methylprednisolone Preparations Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Fuan Pharmaceutical Main Business
Table 142. Fuan Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Methylprednisolone Preparations
Figure 2. Methylprednisolone Preparations Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Methylprednisolone Preparations Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Methylprednisolone Preparations Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Methylprednisolone Preparations Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Injection
Figure 11. Global Methylprednisolone Preparations Sales Market Share by Type in 2022
Figure 12. Global Methylprednisolone Preparations Revenue Market Share by Type (2018-2023)
Figure 13. Methylprednisolone Preparations Consumed in Hospital
Figure 14. Global Methylprednisolone Preparations Market: Hospital (2018-2023) & (K Units)
Figure 15. Methylprednisolone Preparations Consumed in Clinic
Figure 16. Global Methylprednisolone Preparations Market: Clinic (2018-2023) & (K Units)
Figure 17. Methylprednisolone Preparations Consumed in Other
Figure 18. Global Methylprednisolone Preparations Market: Other (2018-2023) & (K Units)
Figure 19. Global Methylprednisolone Preparations Sales Market Share by Application (2022)
Figure 20. Global Methylprednisolone Preparations Revenue Market Share by Application in 2022
Figure 21. Methylprednisolone Preparations Sales Market by Company in 2022 (K Units)
Figure 22. Global Methylprednisolone Preparations Sales Market Share by Company in 2022
Figure 23. Methylprednisolone Preparations Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Methylprednisolone Preparations Revenue Market Share by Company in 2022
Figure 25. Global Methylprednisolone Preparations Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Methylprednisolone Preparations Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Methylprednisolone Preparations Sales 2018-2023 (K Units)
Figure 28. Americas Methylprednisolone Preparations Revenue 2018-2023 ($ Millions)
Figure 29. APAC Methylprednisolone Preparations Sales 2018-2023 (K Units)
Figure 30. APAC Methylprednisolone Preparations Revenue 2018-2023 ($ Millions)
Figure 31. Europe Methylprednisolone Preparations Sales 2018-2023 (K Units)
Figure 32. Europe Methylprednisolone Preparations Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Methylprednisolone Preparations Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Methylprednisolone Preparations Revenue 2018-2023 ($ Millions)
Figure 35. Americas Methylprednisolone Preparations Sales Market Share by Country in 2022
Figure 36. Americas Methylprednisolone Preparations Revenue Market Share by Country in 2022
Figure 37. Americas Methylprednisolone Preparations Sales Market Share by Type (2018-2023)
Figure 38. Americas Methylprednisolone Preparations Sales Market Share by Application (2018-2023)
Figure 39. United States Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Methylprednisolone Preparations Sales Market Share by Region in 2022
Figure 44. APAC Methylprednisolone Preparations Revenue Market Share by Regions in 2022
Figure 45. APAC Methylprednisolone Preparations Sales Market Share by Type (2018-2023)
Figure 46. APAC Methylprednisolone Preparations Sales Market Share by Application (2018-2023)
Figure 47. China Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Methylprednisolone Preparations Sales Market Share by Country in 2022
Figure 55. Europe Methylprednisolone Preparations Revenue Market Share by Country in 2022
Figure 56. Europe Methylprednisolone Preparations Sales Market Share by Type (2018-2023)
Figure 57. Europe Methylprednisolone Preparations Sales Market Share by Application (2018-2023)
Figure 58. Germany Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Methylprednisolone Preparations Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Methylprednisolone Preparations Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Methylprednisolone Preparations Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Methylprednisolone Preparations Sales Market Share by Application (2018-2023)
Figure 67. Egypt Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Methylprednisolone Preparations Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Methylprednisolone Preparations in 2022
Figure 73. Manufacturing Process Analysis of Methylprednisolone Preparations
Figure 74. Industry Chain Structure of Methylprednisolone Preparations
Figure 75. Channels of Distribution
Figure 76. Global Methylprednisolone Preparations Sales Market Forecast by Region (2024-2029)
Figure 77. Global Methylprednisolone Preparations Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Methylprednisolone Preparations Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Methylprednisolone Preparations Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Methylprednisolone Preparations Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Methylprednisolone Preparations Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のメチルプレドニゾロン製剤市場予測 2023年-2029年] (コード：LP23DC11210)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のメチルプレドニゾロン製剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のメチルプレドニゾロンコハク酸ナトリウム注射液市場予測 2023年-2029年
  • 世界のヘミスク酸メチルプレドニゾロンAPI市場予測 2023年-2029年
  • 世界のモンテルカストナトリウム製剤市場予測 2023年-2029年
  • 世界のモンテルカストナトリウム製剤市場予測 2023年-2029年
  • 世界の全身性コルチコステロイド市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆